Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Momenta Pharmaceuticals patents

Patents where

Current Assignee

Name

Momenta Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11352415 Methods for the treatment of neurodegeneration	Patent 11352415 was granted and assigned to Momenta Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	11352415	June 7, 2022
‌ US Patent 11345751 FcRn antibodies and methods of use thereof	Patent 11345751 was granted and assigned to Momenta Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	11345751	May 31, 2022
‌ US Patent 7811827 Methods and apparatus for characterizing heparin-like glycosaminoglycan mixtures	Patent 7811827 was granted and assigned to Momenta Pharmaceuticals on October, 2010 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	7811827	October 12, 2010
‌ US Patent 7407810 Methods and apparatus for characterizing polymeric mixtures	Patent 7407810 was granted and assigned to Momenta Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	7407810	August 5, 2008
‌ US Patent 7575886 Analysis of sulfated polysaccharides	Patent 7575886 was granted and assigned to Momenta Pharmaceuticals on August, 2009 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	7575886	August 18, 2009
‌ US Patent 9182467 Comparative analysis of protein conformations by using 2D NOESY NMR spectra	Patent 9182467 was granted and assigned to Momenta Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	9182467	November 10, 2015
‌ US Patent 10144944 Methods of cell culture	Patent 10144944 was granted and assigned to Momenta Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	10144944	December 4, 2018
‌ US Patent 9475858 Cell culture process	Patent 9475858 was granted and assigned to Momenta Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	9475858	October 25, 2016
‌ US Patent 8956830 Methods of cell culture	Patent 8956830 was granted and assigned to Momenta Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	8956830	February 17, 2015
‌ US Patent 9487810 Methods of cell culture	Patent 9487810 was granted and assigned to Momenta Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	9487810	November 8, 2016
‌ US Patent 9217168 Methods of cell culture	Patent 9217168 was granted and assigned to Momenta Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	9217168	December 22, 2015
‌ US Patent 9663810 Methods of cell culture	Patent 9663810 was granted and assigned to Momenta Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	9663810	May 30, 2017
‌ US Patent 10239944 Compositions and methods related to engineered Fc constructs	Patent 10239944 was granted and assigned to Momenta Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	10239944	March 26, 2019
‌ US Patent 9926583 Methods of cell culture	Patent 9926583 was granted and assigned to Momenta Pharmaceuticals on March, 2018 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	9926583	March 27, 2018
‌ US Patent 9677105 Methods of cell culture	Patent 9677105 was granted and assigned to Momenta Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	9677105	June 13, 2017
‌ US Patent 9650433 Modified glycoproteins	Patent 9650433 was granted and assigned to Momenta Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	9650433	May 16, 2017
‌ US Patent 10377809 Modified glycoproteins	Patent 10377809 was granted and assigned to Momenta Pharmaceuticals on August, 2019 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	10377809	August 13, 2019
‌ US Patent 9890410 N-acetylhexosamine-containing N-glycans in glycoprotein products	Patent 9890410 was granted and assigned to Momenta Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	9890410	February 13, 2018
‌ US Patent 10450361 Methods related to CTLA4-Fc fusion proteins	Patent 10450361 was granted and assigned to Momenta Pharmaceuticals on October, 2019 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	10450361	October 22, 2019
‌ US Patent 9068957 Evaluating heparin preparations	Patent 9068957 was granted and assigned to Momenta Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	9068957	June 30, 2015
‌ US Patent 9395374 Analysis of amino acid copolymer compositions	Patent 9395374 was granted and assigned to Momenta Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	9395374	July 19, 2016
‌ US Patent 9029081 Characterization of N-glycans using exoglycosidases	Patent 9029081 was granted and assigned to Momenta Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	9029081	May 12, 2015
‌ US Patent 8927292 Methods of evaluating peptide mixtures	Patent 8927292 was granted and assigned to Momenta Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.	Momenta Pharmaceuticals	Momenta Pharmaceuticals	United States Patent and Trademark Office	8927292	January 6, 2015
‌ US Patent 7884187 Analysis of amino acid copolymer compositions	Patent 7884187 was granted and assigned to Momenta Pharmaceuticals on February, 2011 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	7884187	February 8, 2011
‌ US Patent 7816144 Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping	Patent 7816144 was granted and assigned to Momenta Pharmaceuticals on October, 2010 by the United States Patent and Trademark Office.		Momenta Pharmaceuticals	United States Patent and Trademark Office	7816144	October 19, 2010

Results per page:

100 results

0 selected

100 results

0 selected